Pasar al contenido principal

Estudio de la vacunómica cuántica para el desarrollo de vacunas para el control de garrapatas

IJC2020-042710-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Juan de la Cierva Incorporación
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Trained immunity is not universal: oral heat-inactivated Mycobacterium bovis confers no protection against the non-enveloped Porcine Circovirus 2

  • Ferreras-Colino, Elisa
  • Barasona, José A.
  • Sibila, Marina
  • Mazariegos, María
  • Vaz Rodrigues, Rita
  • Cruz, Fátima
  • Contreras, Marinela
  • Garrido, Joseba M.
  • Segalés, Joaquim
  • Fuente, José de la
  • Domínguez, Lucas
  • Gortázar, Christian
  • Risalde, María Ángeles
[Background] Trained immunity, the enhanced response of innate cells leading to an improved innate immune response, and antibodies against the glycan galactose-α-1,3-galactose (α-Gal), produced by animals unable to synthesize α-Gal epitopes, have been suggested to provide the host certain advantage in infections with enveloped viruses. Conversely, the evidence of protection against non-enveloped viruses attributed to the referred mechanisms remains scarce. Aiming to evaluate whether a heat-inactivated Mycobacterium bovis (HIMB) immunostimulant, which had proven to protect against related and non-related pathogens, confers an advantage against non-enveloped viruses, we performed an immunization and challenge experiment with porcine circovirus 2 (PCV-2) in swine. Sixteen piglets were randomly assigned to the immunized group (n = 8), which received two oral doses of HIMB with an interval of three weeks, or to the control group (n = 8). All animals were infected by intranasal inoculation with PCV-2 21 days later and euthanized at day 21 post-challenge., [Results] No differences in body weight and body temperature, viremia and viral burden in target tissues, antibody production and histopathological changes in target tissues were observed between the immunized and the control group. Overall, oral immunization with HIMB did not protect pigs against PCV-2 infection., [Conclusions] Our study suggests that HIMB confers no advantage against pathogens lacking α-Gal, mainly non-enveloped viruses such as PCV-2, in α-Gal-producing hosts, such as the swine., The present study has been funded by project MYCOTRAINING SBPLY/19/180501/000174 (Junta de Castilla-La Mancha, Spain, and EU-FEDER). E. Ferreras-Colino (2020/3836) and R. Vaz-Rodrigues (2022/20675) were supported by the predoctoral contract from Universidad de Castilla-La Mancha (UCLM), co-financed by the European Social Fund (ESF). Marinela Contreras was supported by the Ministerio de Ciencia, Innovación y Universidades, Spain, grant IJC2020-042710-I., Peer reviewed